Clin2
NCT07605156Possibly a fitRecruiting

New imaging scan for rare adrenal hormone tumors

Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion

Part of Hormones & metabolism clinical trials.

This study tests a special imaging scan (PET/CT) to help doctors identify adrenal tumors that produce too much of two hormones: aldosterone and cortisol. If you have both hormone imbalances confirmed by blood tests and are planning surgery to remove your adrenal gland, this scan may help your doctors see exactly where the tumor is.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • Age 18–80 years
  • Confirmed diagnosis of primary aldosteronism (high aldosterone-to-renin ratio) plus elevated cortisol on a dexamethasone suppression test
  • Scheduled for adrenal surgery or ablation (minimally invasive treatment)
  • Able to undergo the specialized PET/CT imaging scan with a radioactive tracer
  • Willing to follow up with your medical team for at least 12 months after treatment
  • No previous adrenal surgery and no known adrenal cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06635993Recruiting
Testing a PET scan for aldosterone and cortisol condition

This trial tests whether a special PET/CT scan (68Ga-Pentixafor) can accurately identify the subtype of primary aldosteronism in people who also have excess cortisol. It may help determine if surgery is the right treatment for you.

Chongqing, Chongqing Municipality
NCT06773663Recruiting· Phase 1/Phase 2
New imaging test for adrenal gland hormone disorder

This trial tests a special PET scan that may help doctors find the exact cause of high blood pressure related to an adrenal gland problem. It could help decide if surgery or medicine is the best treatment for you.

Beijing
NCT07350707Recruiting· Phase 1/Phase 2
PET scan for Cushing's syndrome using two tracers

This trial tests if a special PET scan using two different tracers (68Ga-Pentixafor and 68Ga-DOTATATE) can help diagnose Cushing's syndrome and find its cause. It may help doctors better understand your condition and guide treatment.

Beijing, Beijing Municipality
NCT06833437Recruiting
New PET scan versus blood test for adrenal condition

This trial tests a special PET scan (68Ga-Pentixafor) to see if it can replace a more invasive blood test (AVS) for finding which adrenal gland is causing high blood pressure and high cortisol levels. It may help patients avoid a complicated procedure.

Chongqing, Chongqing Municipality
NCT07814105Not yet recruiting
New PET scan for diagnosing adrenal gland disorder

This trial tests a new type of PET scan that may help find which adrenal gland is causing your condition, compared to the usual care. If successful, it could help guide surgery decisions.

Shatin
NCT06246357Recruiting· Phase 2
Testing adrenal gland function with a special scan

This trial uses a special PET scan (68Ga-PentixaFor) to check how well your adrenal glands are working if you have high aldosterone or cortisol levels. It helps doctors see if the glands are making too much hormone, which may guide treatment.

Bethesda, Maryland

Hear when a new Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.